Paulson Funds Rise

Jul 1 2014 | 8:32am ET

Two Paulson & Co. strategies have outdone their peers through the first five months of the year, the firm told clients at its mid-year meeting.

The New York-based hedge fund’s credit opportunities fund is up 6.6% through the end of May, Reuters reports. Firm founder John Paulson said at the June 12 event in London that the portfolio is “fully invested” and designed to continue to earn such returns through next year, “outperforming in a low-yielding environment.”

Paulson also discussed the firm’s merger arbitrage strategy, which is up 3.3% over the same period. He said that merger arbitrage spreads are “becoming attractive,” citing Valeant Pharmaceuticals International’s hostile bid for Allergan Inc. and Mallinckrodt’s deal for Questor Pharma.

The talk came some two weeks before Paulson announced a big stake in Allergan and his support for Valeant’s offer, on which it is working with Pershing Square Capital Management.


In Depth

Debunking Conventional Investment Wisdom

Feb 8 2017 | 3:22pm ET

Due diligence in the hedge fund world has long involved some combination of the...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

iCapital Network: The Trump Effect On Direct Lending

Feb 23 2017 | 4:21pm ET

The arrival of the Trump Administration has raised questions among private debt...

 

From the current issue of